We are live on !
Find out more
Chevy Chase Trust Portfolio holdings
AUM
$39B
Turnover
7.03%
1-Year Est. Return
41.71%
Chevy Chase Trust is an investment management firm owned by the B.F. Saul family. It builds portfolios around global themes for high net worth individuals, families, endowments and institutions. Its themes include the clustering of wealth in productive hubs and the rise of molecular medicine. The firm picks individual stocks and bonds itself, with no outside managers and no funds of its own.
This Fund
S&P 500
This Quarter Est. Return
+24.73%
1 Year Est. Return
+41.71%
3 Year Est. Return
+130.01%
5 Year Est. Return
+174.41%
10 Year Est. Return
+656.87%
AUM
$39B
AUM Growth
+$4.25B
(+12%)
Cap. Flow
-$668M
Cap. Flow % of AUM
Cap. Flow %
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
35.41%
Holding
669
New
27
Increased
64
Reduced
524
Closed
20
Avg Time Held
9
years
Top 10 Avg Time Held
6.6
years
Top 20 Avg Time Held
6.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$84.8M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$34.1M |
| 3 |
Illumina
ILMN
|
+$27.8M |
| 4 |
Flex
FLEX
|
+$21.5M |
| 5 |
SLB Ltd
SLB
|
+$17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$65.4M |
| 2 |
Microsoft
MSFT
|
+$38.2M |
| 3 |
Honeywell
HON
|
+$36.2M |
| 4 |
Apple
AAPL
|
+$35.1M |
| 5 |
Ascendis Pharma A/S
ASND
|
+$28.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.18% |
| 2 | Financials | 12.61% |
| 3 | Communication Services | 9.68% |
| 4 | Healthcare | 9.63% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
iShares S&P 500 Growth ETF
IVW
$74B
| $290K | ﹤0.01% |
2,105
| – | – |
2024 Q2
8 quarters
|
|
627
Badger Meter
BMI
$4.45B
| $286K | ﹤0.01% |
1,929
| – | – |
2020 Q4
22 quarters
|
|
628
Canadian National Railway
CNI
$76.6B
| $276K | ﹤0.01% |
+2,311
| New | +$263K |
2026 Q2
0 quarters
|
|
629
iShares Core S&P Total US Stock Market ETF
ITOT
$95.8B
| $267K | ﹤0.01% |
1,625
| – | – |
2025 Q2
4 quarters
|
|
630
Suncor Energy
SU
$79.8B
| $259K | ﹤0.01% |
4,831
+109
| +2% | +$6.9K |
2025 Q4
2 quarters
|
|
631
State Street SPDR S&P Dividend ETF
SDY
$22.6B
| $258K | ﹤0.01% |
1,695
| – | – |
2025 Q1
5 quarters
|
|
632
iShares MSCI South Korea ETF
EWY
$21.3B
| $253K | ﹤0.01% |
+1,252
| New | +$221K |
2026 Q2
0 quarters
|
|
633
Nortech Systems
NSYS
$31.2M
| $250K | ﹤0.01% |
15,832
| – | – |
2020 Q2
24 quarters
|
|
634
Black Hills Corp
BKH
$6.7B
| $244K | ﹤0.01% |
+3,280
| New | +$242K |
2026 Q2
0 quarters
|
|
635
Vanguard Russell 1000 ETF
VONE
$9.4B
| $239K | ﹤0.01% |
705
| – | – |
2025 Q3
3 quarters
|
|
636
Schwab Fundamental International Large Company Index ETF
FNDF
$25.7B
| $238K | ﹤0.01% |
4,510
| – | – |
2025 Q4
2 quarters
|
|
637
DFA Real Estate Securities Portfolio ETF Class Shares
DFAR
$1.76B
| $235K | ﹤0.01% |
8,984
| – | – |
2024 Q3
7 quarters
|
|
638
Amrize Ltd
AMRZ
$21.7B
| $234K | ﹤0.01% |
4,385
+745
| +20% | +$40.3K |
2026 Q1
1 quarter
|
|
639
Vanguard Consumer Discretionary ETF
VCR
$6.17B
| $229K | ﹤0.01% |
578
-368
| -39% | -$143K |
2024 Q4
6 quarters
|
|
640
Invesco Pharmaceuticals ETF
PJP
$594M
| $225K | ﹤0.01% |
+1,900
| New | +$206K |
2026 Q2
0 quarters
|
|
641
iShares Global Healthcare ETF
IXJ
$4.7B
| $223K | ﹤0.01% |
2,267
-933
| -29% | -$87.8K |
2013 Q2
52 quarters
|
|
642
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
| $222K | ﹤0.01% |
3,283
-3,283
| -50% | -$211K |
2024 Q4
6 quarters
|
|
643
Dimensional International Core Equity Market ETF
DFAI
$18.2B
| $218K | ﹤0.01% |
5,287
-414
| -7% | -$17K |
2026 Q1
1 quarter
|
|
644
Equitable Holdings
EQH
$14.8B
| $213K | ﹤0.01% |
+4,848
| New | +$203K |
2026 Q2
0 quarters
|
|
645
Ralliant Corp
RAL
$7.82B
| $212K | ﹤0.01% |
+2,885
| New | +$161K |
2026 Q2
0 quarters
|
|
646
HEICO Corp Class A
HEI.A
$35.5B
| $211K | ﹤0.01% |
+820
| New | +$187K |
2026 Q2
0 quarters
|
|
647
RB Global
RBA
$17.1B
| $204K | ﹤0.01% |
+1,750
| New | +$184K |
2026 Q2
0 quarters
|
|
648
WSFS Financial
WSFS
$4.04B
| $203K | ﹤0.01% |
+2,650
| New | +$190K |
2026 Q2
0 quarters
|
|
649
Caribou Biosciences
CRBU
$41.1M
| $17.6K | ﹤0.01% |
10,000
| – | – |
2025 Q1
5 quarters
|
|
|
650
Ascendis Pharma A/S
ASND
$17.6B
| – | – |
-123,467
| Closed | -$28.2M | – |
|
Similar funds
VARA
Chevy Chase Trust's Q2 2026 Portfolio in Review
As of Q2 2026, Chevy Chase Trust held 669 positions worth $39B, up 12% from $34.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Chevy Chase Trust's Q2 2026 filing shows 27 new, 64 increased, 524 reduced and 20 closed positions. Its largest new stake was Marvell Technology: 422,775 shares worth $126M. The largest sale was NVIDIA, an estimated $65.4M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 32% a quarter earlier, followed by Financials and Communication Services.
- Chevy Chase Trust's largest Q2 2026 buy was Marvell Technology: 422,775 shares worth $126M.
- Chevy Chase Trust added most to Illumina in Q2 2026, an estimated $27.8M increase.
- Chevy Chase Trust's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $65.4M.
- Chevy Chase Trust fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $28.2M.
- Chevy Chase Trust's ten largest holdings make up 35% of its $39B portfolio in Q2 2026.
- Chevy Chase Trust opened 27 new positions and closed 20 in Q2 2026.
- Chevy Chase Trust's portfolio value rose 12% quarter-over-quarter to $39B.
Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.